Kang-Un Choi

Dr. Kang-Un Choi


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Jah Yeon ChoiJah Yeon Choi
Jah Yeon Choi
YSYoung Joo Suh
Young Joo Suh
JSJiwon Seo
Jiwon Seo
KCKang-Un Choi
Kang-Un Choi
GHGeu-Ru Hong
Geu-Ru Hong
CSChi Young Shim
Chi Young Shim
Objective: Clinical presentation of patients with mitral paravalvular leakage (PVL) varies from asymptomatic to heart failure related with hemolytic anemia or pulmonary hypertension. We aimed to investigate the structural and functional characteristics of mitral PVL by multimodal imaging and their association with the severity of hemolysis and hemodynamic significance. Methods: A total of 74 patients with mitral PVL who underwent both cardiac computed tomography (CT) and echocardiography from March 2010 to December 2017 was investigated. Location and size of PVL, degree of left atrial (LA) calcification as measured by CT, and hemodynamic variables as measured by echocardiography were comprehensively analyzed. To investigate the degree of hemolysis and pulmonary hypertension, level of lactate dehydrogenase (LDH) and Doppler estimated systolic pulmonary artery pressure (SPAP) were used respectively. Results: Level of LDH was not related to PVL perimeter and was variable, especially in patients with a small PVL. However, it was positively correlated with mean mitral regurgitation velocity. Additionally, SPAP was significantly correlated with PVL perimeter and LA calcium score. In multivariable analysis, mean mitral regurgitation velocity was significantly correlated with levels of LDH (β = 0.345; p = 0.016), and PVL perimeter and LA calcium score were independently associated with SPAP (β = 0.249; p = 0.036 and β = 0.467; p < 0.001, respectively). Conclusions: Characteristics of mitral PVL and adjacent structures are associated with the severity of hemolysis and pulmonary hypertension. Evaluating the structural and functional characteristics of mitral PVL by complementary multimodal imaging would be important for understanding the clinical presentation and deciding optimal treatments for individual patients.

1 January 2019 in Yonsei Medical Journal
Verified
Journal Article
Open access
HJHyeonju Jeong
Hyeonju Jeong
CSChi Young Shim
Chi Young Shim
DKDarae Kim
Darae Kim
Jah Yeon ChoiJah Yeon Choi
Jah Yeon Choi
KCKang-Un Choi
Kang-Un Choi
JHJong-Won Ha
Jong-Won Ha
The present study aimed to investigate the prevalence, characteristics, and clinical significance of concomitant specific cardiomyopathies in subjects with bicuspid aortic valves (BAVs). A total of 1186 adults with BAV (850 males, mean age 56±14 years) at a single tertiary center were comprehensively reviewed. Left ventricular non-compaction, hypertrophic cardiomyopathy, and idiopathic dilated cardiomyopathy were confirmed when patients fulfilled current clinical and echocardiographic criteria. Clinical and echocardiographic characteristics, including comorbidities, heart failure presentation, BAV morphology, function, and aorta phenotypes, in BAV subjects with or without specific cardiomyopathies were compared. Overall, 67 subjects (5.6%) had concomitant cardiomyopathies: 40 (3.4%) patients with left ventricular non-compaction, 17 (1.4%) with hypertrophic cardiomyopathy, and 10 (0.8%) with dilated cardiomyopathy. BAV subjects with hypertrophic cardiomyopathy had higher prevalences of diabetes mellitus and heart failure with preserved ejection fraction, and tended to have type 0 phenotype, while BAV subjects with dilated cardiomyopathy showed higher prevalences of chronic kidney disease and heart failure with reduced ejection fraction. BAV subjects with left ventricular non-compaction were significantly younger and predominantly male, and had greater BAV dysfunction and a higher prevalence of normal aorta shape. In multiple regression analysis, cardiomyopathy was independently associated with heart failure (odds ratio 2.795, 95% confidential interval 1.603-4.873, p<0.001) after controlling for confounding factors. Concomitant cardiomyopathies were observed in 5.6% of subjects with BAV. A few different clinical and echocardiographic characteristics were found. The presence of cardiomyopathy was independently associated with heart failure.

23 December 2024 in Journal of Asian Pacific Society of Cardiology
Verified
Journal Article
Open access
PDF file
RSRaja Ezman Raja Shariff
Raja Ezman Raja Shariff
HJHaowen Jiang
Haowen Jiang
JYJonathan Yap
Jonathan Yap
STShyn Yi Tan
Shyn Yi Tan
LCLucky Cuenza
Lucky Cuenza
CTCaitlyn Tan
Caitlyn Tan
There remains great heterogeneity in the availability of data and approaches in managing hypertension in Asia-Pacific. A narrative review was performed to better understand the epidemiology of hypertension and challenges in hypertension care provision regionally. The data obtained were discussed under five domains: epidemiology; hospitalisation and financial impact; medication prescription; national guidelines, societies and measures; and barriers and challenges in managing hypertension. Sixteen countries were included, with the prevalence of hypertension ranging between 10.6% and 48.3%. Rates of undiagnosed, untreated and uncontrolled hypertension were alarming throughout the region, with various factors from the five major domains contributing to this, such as urbanisation, gender and socioeconomic status. Data on care provision were generally sparse. Although various measures and policies exist in individual countries to help combat hypertension, challenges have also been identified: some are systemic, while others appear more granular and culturally influenced. Collaboration between stakeholders between countries is crucial to effectively tackle these issues.

4 March 2024 in Clinical Cardiology
Verified
Journal Article
Open access
JKJee‐Heon Kim
Jee‐Heon Kim
YYYoung‐Chae Yoon
Young‐Chae Yoon
YKYoung‐Hoon Kim
Young‐Hoon Kim
JPJong‐Il Park
Jong‐Il Park
KCKang-Un Choi
Kang-Un Choi
UKUng Kim
Ung Kim
Background: Sodium‐glucose co‐transporter 2 (SGLT2) inhibitors have been demonstrated to decrease cardiovascular adverse events. However, there is little real‐world clinical evidence regarding a direct comparison between dapagliflozin and empagliflozin in patients with diabetes mellitus (DM).Hypothesis: A difference in the cardiovascular efficancy of dapagliflozin versus empagliflozin in DM patients was anticipated, aiming to guide the optimal choice of SGLT2 inhibitors based on cardiovascular outcomes.Methods: From 2014 to 2020, a total of 1549 patients with DM who were prescribed SGLT2 inhibitors such as dapagliflozin or empagliflozin were retrospectively enrolled. We categorized the study population into two groups: dapagliflozin (n = 981) and empagliflozin group (n = 568). The primary endpoint was major adverse cardiovascular events (MACE), defined as a composite of all‐cause death, myocardial infarction (MI), stroke, or hospitalization for heart failure (HF) over a 3‐year period.Results: Propensity‐score matching was performed (537 patients in each group). The mean age and hemoglobin A1c were 58.2 ± 13.0 years and 8.4 ± 1.7%, respectively. There was no significant difference between the dapagliflozin and empagliflozin groups in the risk of MACE (3.7% vs. 4.8%, hazard ratio [HR], 1.31; 95% confidence interval [CI], 0.73–2.35; p = 0.349). Furthermore, there were no differences between the two groups in secondary endpoints including all‐cause death, MI, stroke, and hospitalization for HF. Prior MI and history of HF were independent predictors of MACE.Conclusions: Dapagliflozin and empagliflozin showed no significant difference of real‐world clinical cardiovascular outcomes in patients with DM over a 3‐year period. Further large randomized clinical trials will be warranted for better evaluation.

1 January 2026 in International Journal of Heart Failure
Verified
Journal Article
Open access
PDF file
CLChan Joo Lee
Chan Joo Lee
HLHokyou Lee
Hokyou Lee
KKKyu-yong Ko
Kyu-yong Ko
MKMin Gyu Kong
Min Gyu Kong
MKMin Sun Kim
Min Sun Kim
Byung Su YooByung Su Yoo
Byung Su Yoo
Lee CJ, et al. Int J Heart Fail. 2026 Jan;8(1):58-73. https://doi.org/10.36628/ijhf.2026.0001

1 January 2020 in Korean Circulation Journal
Verified
Journal Article
Open access
BKByong-Kyu Kim
Byong-Kyu Kim
DNDeuk-Young Nah
Deuk-Young Nah
KCKang-Un Choi
Kang-Un Choi
JBJun-Ho Bae
Jun-Ho Bae
MRMoo-Yong Rhee
Moo-Yong Rhee
MHMin Su Hyon
Min Su Hyon
Background and Objectives: The relationship between the hospital percutaneous coronary intervention (PCI) volumes and the in-hospital clinical outcomes of patients with acute myocardial infarction (AMI) remains the subject of debate. This study aimed to determine whether the in-hospital clinical outcomes of patients with AMI in Korea are significantly associated with hospital PCI volumes. Methods: We selected and analyzed 17,121 cases of AMI, that is, 8,839 cases of non-ST-segment elevation myocardial infarction and 8,282 cases of ST-segment elevation myocardial infarction, enrolled in the 2014 Korean percutaneous coronary intervention (K-PCI) registry. Patients were divided into 2 groups according to hospital annual PCI volume, that is, to a high-volume group (>= 400/year) or a low-volume group (<400/year). Major adverse cardiovascular and cerebrovascular events (MACCEs) were defined as composites of death, cardiac death, non-fatal myocardial infarction (MI), stent thrombosis, stroke, and need for urgent PCI during index admission after PCI. Results: Rates of MACCE and non-fatal MI were higher in the low-volume group than in the high-volume group (MACCE: 10.9%vs. 8.6%, p=0.001; non-fatal MI: 4.8% vs. 2.6%, p=0.001, respectively). Multivariate regression analysis showed PCI volume did not independently predict MACCE. Conclusions: Hospital PCI volume was not found to be an independent predictor of inhospital clinical outcomes in patients with AMI included in the 2014 K-PCI registry.